Trials / Completed
CompletedNCT01488851
Study to Assess Incidence of ONJ in Pts With Bone Mets Starting Zoledronic Acid Treatment
Prospective Observational Multi Central Cohort Study to Assess the Incidence of Osteo Necrosis of Jaw in Patients With Bone Metastasis Starting Zoledronic Acid Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective observational multi central cohort study to assess the incidence of osteo necrosis of jaw in cancer patient with bone metastasis starting Zoledronic acid treatment
Detailed description
Prospective observational multi central cohort study to assess the incidence of osteo necrosis of jaw (ONJ) in pts with bone metastasis starting Zoledronic acid treatment
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-01-01
- Completion
- 2015-01-01
- First posted
- 2011-12-08
- Last updated
- 2019-03-01
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01488851. Inclusion in this directory is not an endorsement.